Key result
Combining poly r(A-U) with riboflavin, FAD, or FMN potentiated its antiviral activity seven- to twelve-fold in a human foreskin fibroblast-vesicular stomatitis virus bioassay.
Riboflavin, FAD, and FMN potentiate the antiviral activity of poly r(A-U) in vitro.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for flavin-enhanced antivirals; leaves open clinical relevance pending in vivo validation.
The role of riboflavin (RFN), FAD or FMN in modulating the antiviral activity of poly r(A-U) was examined by the human foreskin fibroblast-vesicular stomatitis virus bioassay in which the concentrations of poly r(A-U) was fixed at 0.1 mM or 0.2 mM while the riboflavin, FAD or FMN concentration was varied to produce variable RFN (or FAD or FMN)/ribonucleotide ratios ranging from 1/16 to 2/1. Riboflavin, FAD and FMN tested individually did not exhibit any antiviral activity, while poly r(A-U) alone exhibited antiviral activity. When poly r(A-U) was combined with riboflavin, FAD or FMN, the antiviral activity was potentiated seven- to twelve-fold at RFN (or FAD or FMN)/ribonucleotide ratios in the region of 1/4.
No takes yet. Share an insight, caveat, or question.
Jamison et al. (1989) studied vesicular stomatitis virus (in vitro). poly r(A-U) combined with riboflavin, FAD or FMN vs. poly r(A-U) alone or riboflavin/FAD/FMN alone was evaluated on antiviral activity (7- to 12-fold potentiation). Combining poly r(A-U) with riboflavin, FAD, or FMN potentiated its antiviral activity seven- to twelve-fold in a human foreskin fibroblast-vesicular stomatitis virus bioassay.
Synapse has enriched 10 related papers. Consider them for comparative context: